Ovarian, colorectal, and pancreatic cancer markers plus metabolic risk factors
Other Labs
Starting at $600
+ lab fees
TestWell
$299.99
The Women's Cancer Screening Panel combines direct tumor markers with metabolic indicators linked to cancer risk. CA-125 screens for ovarian cancer — elevated levels can indicate ovarian malignancy, endometriosis, or other pelvic conditions. CEA screens for colorectal cancer, CA 19-9 for pancreatic cancer, and AFP for liver cancer. These are complemented by metabolic markers — elevated insulin and IGF-1 are associated with increased cancer risk, LDH is elevated in many cancers, hs-CRP measures systemic inflammation linked to cancer progression, and ferritin can be elevated in certain malignancies. CBC and CMP provide baseline blood health and organ function context. This panel is not diagnostic — it is a screening tool best used as part of regular preventive care.
Women's cancer screening biomarkers: CA-125 (ovarian), CA 15-3 (breast), CA 19-9 (pancreatic/GI), CEA (colorectal/general), FIT Test (colon), CBC, LDH. Surveillance panel for women 40+ with risk factors.
Women 50+ for routine cancer surveillance, women 40+ with family history (especially BRCA1/2 carriers), women with persistent unexplained symptoms, survivors monitoring for recurrence. Not a substitute for mammogram, Pap smear, or colonoscopy.
Sample Type
Blood draw
Fasting
Required
Results In
3–5 business days
Tests Included
12 tests
12 individual tests — each one linked so you can learn more.
Fasting for 8–12 hours is recommended. Inform your provider if you are menstruating, pregnant, or have known endometriosis, as these can affect CA-125 levels.
Fasting for 8–12 hours is recommended. Inform your provider if you are menstruating, pregnant, or have known endometriosis, as these can affect CA-125 levels.
Starting at $600 at other labs
TestWell Price
$299.99
+ $6 lab processing fee at checkout
No insurance needed · HIPAA compliant
Individual tests that complement this panel
Women's Cancer Screening Panel
$299.99